Fda clears Roche and Eli Lilly blood test expanding Alzheimer diagnosis

The FDA has approved Elecsys Phospho-Tau 217, a blood test co-developed by Roche Diagnostics and Eli Lilly, to aid in early Alzheimer's diagnosis. This test allows simpler and more accessible screening for amyloid plaque accumulation compared to previous expensive and invasive methods like PET scans.

This Wire brief sits within Fusion42's coverage of Health, and 3 sources have reported it between 25 Aug 2026 and 3 Sep 2026.